After WHO nod to Pfizer vaccine, expert panel in India to meet today to approve Covid 19 vaccines—Covishield and Covaxin—for emergency use
An expert panel in the Central Drugs Standard Control Organisation (CDSCO) in India will hold a key meeting on Friday to consider emergency use authorisation applications by the Serum Institute of India (SII) for the Oxford-AstraZeneca vaccine ‘Covishield’ and Bharat Biotech for its COVID-19 vaccine ‘Covaxin’.
“The SEC in the CDSCO met today in the afternoon to consider the emergency use authorisation (EUA) request of Pfizer, SII and Bharat Biotech,” the Health Ministry had said in a statement on Wednesday. Source: PTI